Purpose: Conjunctival specimens from primary open-angle glaucoma (POAG), exfoliation glaucoma (ExG) patients and controls were histologically analysed for oxidized low-density lipoprotein (ox-LDL), lipid and calcium aggregates. Our goal was to use them as biomarkers of oxidative stress and inflammation and to evaluate their correlation with glaucoma and impact on surgical outcome. Methods: Conjunctival samples were obtained from POAG (n = 14) and ExG (n = 17) patients and from control subjects (n = 11) operated for macular hole, retinal detachment or strabismus. Immunohistochemistry was performed using the antibody against ox-LDL. Lipids and calcium were analysed by histochemical stainings with Nile red and Alizarin red S, respectively. Results: Immunoreaction for ox-LDL was significantly increased in POAG (p = 0.049) and the number of lipid aggregates was significantly higher in ExG (p = 0.009) when compared to control. When POAG and ExG patients were grouped according to the outcome of deep sclerectomy (DS) surgery, the number of lipid (p < 0.001) and calcium aggregates (p = 0.014) were significantly higher in the conjunctival stroma of patients whose surgery failed within a three-year follow-up period. Conclusions: The lipid-mediated alterations suggested the presence of oxidative stress and inflammation in the conjunctiva of glaucoma patients. The present data further support the role of oxidative stress and inflammation in the wound healing process leading to excessive scarring and failure in DS surgery.
Introduction
Deep sclerectomy (DS) is a non-penetrating filtration procedure without the need to enter the anterior chamber (Johnson & Johnson 2002) . The advantages of DS compared with trabeculectomy include fewer postoperative complications, smaller risk of surgically induced inflammation, minimal visual acuity reduction and the absence of induced cataract (Mermoud & Schnyder 2000; Shaarawy & Bhartiya 2011) . However, as with glaucoma surgery in general, the state of the conjunctiva is an important factor for the success of DS (Helin et al. 2011) . Chronic topical glaucoma treatment especially with preserved antiglaucoma drugs induces subclinical conjunctival changes which may increase scarring and failure of glaucoma surgery (Broadway et al. 1994b; Pisella et al. 2004; Helin et al. 2011; Boimer & Birt 2013; Izzotti et al. 2015) .
Oxidative stress and inflammation play a critical synergistic role in many diseases such as atherosclerosis, agerelated macular degeneration, cancer, diabetes, neurodegenerative diseases and pulmonary diseases (Alexander 1995; MacNee 2001; Hald & Lotharius 2005; Gehrs et al. 2006; Hotamisligil 2006; Singh & Jialal 2006; Reuter et al. 2010; Klein et al. 2014) . The imbalance between the production of free radicals reactive oxygen species and endogenous antioxidant defence system results in elevation of markers indicating oxidative stress (C-reactive protein, cytokines, ox-LDL, glutathione peroxidase, sPLA 2 -IIA, matrix metalloproteinases [MMPs] ; Grieve & Shah 2003; Vande rLaan et al. 2004; Koenig & Khuseyinova 2007) . Hypertension, oxygen free radicals, inflammatory processes and lipid peroxidation products trigger a cascade of biological events in which lipid, collagen and calcium accumulate in the wall of an artery and form plaques. Oxidized low-density lipoprotein (ox-LDL) is probably one of the most important and critical factors in the process in which it attracts inflammatory cells and enhances foam cell formation among other things (Fan & Watanabe 2003; Singh & Jialal 2006) .
This study was designed to address, using ox-LDL and lipid and calcium aggregates as biomarkers, whether primary open-angle glaucoma (POAG) and exfoliation glaucoma (ExG) patients, subjected to DS glaucoma surgery, have more oxidative stress and inflammation in their conjunctiva compared with control subjects, and whether this has an effect on the success of glaucoma surgery. We further investigated whether we could find a correlation between previous medical treatment history and either our markers or the surgical outcome of DS.
Materials and Methods

Samples
The study was approved by the Ethics Committee of the Kuopio University Hospital and performed according to the tenets of the Declaration of Helsinki. All the patients gave their informed consent before entering the study. The patients were a part of the three-year follow-up study (R€ onkk€ o et al. 2007a) and were selected for the present study on the basis of the surgical success and type of glaucoma.
All patients were treated preoperatively with combinations of different BAK-preserved antiglaucoma drugs, and no steroids were applied (Table 1) . All patients underwent a comprehensive preoperative ophthalmological examination (Ollikainen et al. 2010) . Conjunctival biopsies were obtained during mitomycin-C augmented DS surgery with collagen implant from POAG (n = 14) and ExG (n = 17) patients. The surgical procedure was standardized and carried out as described earlier (Ollikainen et al. 2010 and performed by three experienced surgeons (M.T., T.P., P.R.). All surgically obtained tissue samples were always taken from the same area, that is the edge of the limbus-based conjunctival flap to avoid regional differences. MMC was applied for 2 min. To prevent or slow disease progression, surgical success was defined as an intraocular pressure (IOP) less than, or equal to, 18 mmHg without the need for glaucoma medication or repeated surgery. According to the study protocol, the postoperative follow-up was 3 years (average 2.8 AE 0.7 years, range 0.2-4.5 years). Patient SK144 (ExG) died during the postoperative period, and we only received preoperative clinical data and a conjunctival biopsy from this patient. There were also five patients (SK34, SK68, SK71, SK73 and SK79) who were no longer study patients at the time of the postoperative follow-up.
Conjunctival biopsies were also retrieved from patients (n = 11) undergoing surgery for macular hole, retinal detachment or strabismus to serve as control subjects. The ocular surface of control patients was assessed by biomicroscopical examination, and the finding was normal for all controls. The control subjects did not receive any antiglaucoma or other topical drugs.
Surgically removed tissue samples were frozen in À70°C until used. Thin (5 lm) cryostat (Leica CM3050S, Leica Microsystems, Nussloch, Germany) sections were placed on Super Frost (Greenspan et al. 1985) . The antibodies for demonstrating ox-LDL were all used at a dilution of 1:2000. We also stained negative control samples in which the respective antibody was omitted from the staining process. Samples were photographed with a Nikon Eclipse TE300 inverted microscope (Nikon, Tokyo, Japan) equipped with Nikon E995 digital camera (Nikon). Images were processed using Adobe Photoshop CS (version 8.0).
Nile red staining
The lipophilic dye Nile red (Invitrogen) was used for detecting lipid deposits. Nile red is a fluorescent dye which stains neutral lipids in green and polar lipids in red and its fluorescence is directly dependent on hydrophobicity of the surrounding environment (Fenyo & Gafencu 2013) . Therefore, it was possible to detect neutral lipids (yellow gold colour; 530-560 nm) and polar lipids, that is phospholipids and cholesterol (orange red colour; emission wavelength greater than 590 nm). Frozen sections were fixed with 4% paraformaldehyde in Tris-buffered saline (TBS) for 30 min and stained with Nile red acetone stock solution diluted in TBS (final concentration:10 lg/ml) for 15 min. Slides were coverslipped with Mowiol 4-48 Reagent (Calbiochem) and stored in the dark at 4°C before microscopic examination. Sections were examined by fluorescence microscope (Olympus BX-40; Olympus Optical Co, LTD, Tokyo, Japan) using a 409 objective lens (UPlanFL; Olympus Optical Co, LTD). The Nile red fluorescence of polar lipids was examined using 540 AE 12 excitation filter and 590 longpass emission filter. Images were taken with Olympus DP50 camera (Olympus Optical Co, LTD) and processed with Viewfinder Lite software (version 1.0; Pixera Corporation, Egham, UK).
Alizarin red S staining
For visualization of calcification, frozen sections were stained with Alizarin red S monohydrate (MP Biomedicals, LLC, Solon, OH, USA). Frozen sections were fixed in acetone for 7 min. Sections were washed in TBS at least three times and placed in 2% (w/v distilled water) Alizarin red S solution (pH 4.1-4.3) for 30 seconds followed by a rinse of distilled water. After staining, slides were counterstained with Harris' haematoxylin (Merck, Darmstadt, Germany). Slides were dehydrated with acetone and xylene and coverslipped with Depex (BDH Laboratories Supplies, London, UK).
Quantification of staining and density of aggregates
To avoid difficulties and misinterpretations related to visual semiquantitative analysis of staining, the immunohistochemical staining of ox-LDL in the conjunctiva was quantified by using Photoshop-based image analysis as described in detail previously (R€ onkk€ o et al. 2007a ). All of digital images (including negative control subjects) were first converted to 8-bit greyscale. The histological area of interest (stroma versus epithelium) was then highlighted using the Magic Wand tool. The Histogram command obtained an optical density plot from the selected area and, furthermore, the mean staining intensities. The staining intensities in arbitrary units (AU) were calculated as the difference in AU between the experimental and corresponding negative control sample.
The numbers of lipid and calcium aggregates were quantified from the stroma and epithelium. Similar Photoshop-based analysis was performed to obtain the dimension of the area and final calculations revealed the numbers of aggregates in the stroma or epithelium (aggregates/mm 2 ).
Statistical analysis
Differences between patient groups and controls were compared using the Mann-Whitney rank sum test. A probability value of <0.05 was considered statistically significant. We also compared the relationship between demographic parameters (age, IOP, duration of treatment of each individual drug, total duration of preoperative topical treatment, duration of glaucoma, number of medication) and ox-LDL expression, as well as the accumulation of lipid and calcium using Spearman's rank-order correlation coefficient. Due to multiple comparisons, we used the Bonferroni correction method.
Results
Demographic and clinical data
The mean age for POAG patients was 65.9 AE 12.1 (mean AE SD) years, 68.7 AE 7.8 years for ExG patients and 62.6 AE 11.9 for control subjects. The average preoperative IOP value for POAG was 24.6 AE 4.7 mmHg and 23.7 AE 7.4 mmHg in ExG. All patients underwent mitomycin-C augmented DS surgery with implant and had received preoperative treatment with several classes of BAK-preserved topical drugs (Table 1 ). From our 31 study patients, 16 were successfully operated and nine failed DS operation. Surgical outcome data were not available for six patients as one patient (SK144) died during the postoperative follow-up and another five patients (SK34, SK68, SK71, SK73 and SK79) were lost to follow-up. These patients were excluded from analyses concerning surgical outcome; that is,12 POAG and 13 ExG samples were analysed.
The patients were most frequently treated with b-blockers (timolol) and prostaglandin analogs (latanoprost) followed by carbonic anhydrase inhibitors (dorzolamide) and a-adrenergic agonists (brimonidine; Table 2 ). Miotics and sympathomimetics were seldom used.
Conjunctival ox-LDL
Ox-LDL staining was seen in stromal cells and extracellular stroma. The extracellular staining was quite evenly distributed and was more intense in POAG and ExG samples than in controls. In addition, ox-LDL immunostaining often gave an impression of ox-LDL-positive 'aggregates' associated with ox-LDL-positive cells in patient groups. In the epithelium, the distribution of ox-LDL was patchy and uneven in all groups (Fig. 1) . The intensity of ox-LDL staining was lower in the epithelium than in the stroma in all groups.
We measured the staining intensity of the samples with the Photoshopbased image analysis program. In the conjunctival stroma, the levels of ox-LDL were significantly higher (p = 0.049) in POAG samples compared with those in controls (Table 3) . There was no statistically significant difference in the levels of ox-LDL between ExG and the control group. In the conjunctival epithelium, there were no significant differences in ox-LDL levels between the groups. Negative control samples did not show signs of immunohistochemical staining of ox-LDL.
Lipid aggregates in the conjunctiva
Frozen tissue sections were stained with Nile red which led to a better visualization of lipid aggregates in the conjunctiva of POAG and ExG patients. In the stroma, the number of lipid aggregates was significantly higher (p = 0.009) in ExG when compared to control (Table 3 ). In addition, more detailed examination of the Nile red-stained samples revealed that the number of these aggregates was the highest in the stroma of patients who had failed DS compared with either successfully operated (p < 0.001) or controls (p < 0.001; Fig. 2, Table 4 ). Occasionally among these patients, we observed few lipid-laden cells between lipid aggregates in the stroma (Fig. 2B) . In the conjunctival epithelium, there were no significant differences in the number of aggregates between patient groups and controls.
Calcium aggregates in the conjunctiva
Because lipids formed aggregates in the conjunctiva, we also visualized calcium deposits in the lipid aggregates with Alizarin red S. A few calcium aggregates were found in the stroma of POAG and ExG patients but they were virtually absent in the controls. Occasionally some cells were located inside these calcium aggregates. In the epithelium, we only observed a faint background staining of Alizarin red S. The presence of calcium aggregates in the conjunctival stroma was significantly more abundant in patients who had failed DS operation compared with successfully operated patients (p = 0.014; Fig. 3 , Table 4 ) and controls (p = 0.002).
Correlations between demographic data and conjunctival parameters
We used the Spearman rank-order test to calculate correlations between demographic data (age, IOP, length of each topical medication, total length of topical medications, duration of glaucoma, number of medication) and conjunctival parameters (level of the ox-LDL, the number of lipid or calcium aggregates) in POAG and ExG. After the Bonferroni correction, the level of statistical significance was set at 0.005 (0.05/10). No correlations were found between the observed conjunctival parameters and demographic data.
Discussion
In the present study, we investigated the immunohistochemical staining of ox-LDL, lipid and calcium aggregates in the conjunctiva of POAG and ExG patients. In addition, we evaluated the prognostic significance of these conjunctival parameters for the outcome of DS operation. To our knowledge, this is the first study that has focused on these factors in the conjunctiva of glaucomatous patients. We divided the patients into two different ways: according to the type of glaucoma and surgery outcome. When compared to control subjects, the levels of ox-LDL were significantly elevated in the conjunctiva of POAG patients and lipid aggregates were more common in ExG patients. On the other hand, we did not observe differences of stromal calcium aggregates between glaucoma patients and controls. When patients were divided according to the surgery outcome, the number of lipid and calcium aggregates was significantly higher in the conjunctival stroma of patients with failed surgery when compared to the success group and controls. These findings indicate the presence of inflammation and oxidative stress in the conjunctiva of chronically treated glaucoma patients and the role of these in the wound healing process after DS. Stromal calcium aggregates may serve as a failure marker for surgical outcome, rather than an indicator of inflammation/oxidative stress. However, this result should be interpreted critically because there were considerable individual variations in the number of these aggregates in patient samples and controls and this is a subject for further investigation.
The role of ox-LDL as an active player in inflammatory and oxidative cascades is well known in atherosclerosis formation and progression (Fan & Watanabe 2003; Singh & Jialal 2006) . Structurally modified LDL attracts monocytes which, in tissues, are then differentiated into macrophages. Macrophages further phagocytose cholesterol molecules and are transformed into foam cells eventually forming a plaque in the arterial wall (Fenyo & Gafencu 2013) . The results of this research showed that in the conjunctival stroma, the staining intensity of ox-LDL was higher in POAG samples when compared to controls. In ExG, the ox-LDL level was also increased but there was no statistically significant difference. It has been previously found that oxidative damage occurs in the trabecular meshwork both in POAG and ExG (Izzotti et al. 2015) . These results are also in accordance with our previous data showing inflammatory cells in the conjunctival stroma being more common in glaucoma patients than controls (Helin et al. 2011 ) and further support the idea of the clinical significance of inflammation and oxidative stress in the conjunctiva of glaucoma patients.
Another known marker for oxidative stress, sPLA 2 -IIA, has also been shown to be present in ocular structures, for example trabecular meshwork and conjunctiva (R€ onkk€ o et al. 2007b; Helin et al. 2008) . sPLA 2 -IIA has been linked as a prognostic biomarker for atherosclerosis (Divchev & Schieffer 2008) . Phospholipases are found in the atherosclerotic aortic walls and the extent of sPLA 2 s is related to advancing atherosclerosis (Kimura-Matsumoto et al. 2008) . sPLA 2 -IIA can interact with circulating LDL in modifying its structure, which can result in more aggressive lipid accumulation on vessel walls (HurtCamejo et al. 2000; Hakala et al. 2001) . Based on this and increased expression of sPLA 2 -IIA found in the trabecular meshwork tissue of POAG patients, it has been proposed that vascular diseases and POAG may have similarities in their pathophysiological mechanisms (R€ onkk€ o et al. 2007b ). This proposition has further been confirmed by Sacc a and colleagues by indicating several proteins related to atherosclerosis development in the aqueous humour of POAG patients (Sacc a et al. 2012 ). Furthermore, it is possible that the TM cells are undergoing a mineralization process resembling that of seen in calcified atherosclerotic arteries, as the gene encoding the inhibitor of calcification Matrix Gla is highly expressed in the TM and induces calcifying activity in the TM cells (Sacc a et al. 2016 ). We have previously also shown that the expression of sPLA 2 -IIA was significantly increased in the conjunctival stroma of POAG and ExG patients (Helin et al. 2008) . In the present study, the expression levels of ox-LDL were generally increased in patient samples and we also observed dense ox-LDL particles in the stroma. Therefore, sPLA 2 -IIA and ox-LDL may co-operate in the conjunctival stroma of glaucomatous patients similarly as they are doing in the vascular tissues in the pathogenesis of atherosclerosis. Failure in glaucoma surgery is usually related to an excessive wound healing process, for example subconjunctival fibrosis leading to scar tissue formation that eventually results in sealing of the scleral flap. Scar tissue is created by fibrocytes that migrate from episcleral tissues, subconjunctival connective tissue and the Tenon 0 s capsule (Maumenee 1960; Daniels et al. 1998; Lama & Fechtner 2003; Atreides et al. 2004; Weinreb & Khaw 2004) . During surgery, anticancer agents, such as 5-FU or mitomycin-C, have been applied to prevent scarring, but certain patient groups still fail filtration surgery (Daniels et al. 1998; Rekonen et al. 2006) . Our standard DS procedure was performed with the use of mitomycin-C (Ollikainen et al. 2010 . We found that failure in DS was associated with significant increase in the number of lipid and calcium aggregates in the conjunctival stroma of glaucoma patients. It is thought that lipid accumulation and oxidation stimulate vascular calcification (Parhami et al. 1997; Tang et al. 2006 ) and on the other hand, vascular calcification is related to advanced atherosclerosis (Raggi et al. 2000) . Therefore, it may be possible that oxidized lipids increase mineralization in the conjunctival stroma of POAG and ExG patients with failed DS operation. Under inflammatory conditions, the normal lipid metabolism may alter leading to excess lipid accumulation potentially resulting in acceleration of extracellular matrix production and fibrosis. The involvement of lipid metabolism in scarring of tissues has been demonstrated in kidney and skin (Abrass 2004; Huang & Ogawa 2013) . Coupling all these findings with our data, it is tempting to speculate that accumulation of lipid and calcium in the conjunctiva of POAG and ExG patients is linked to extensive postoperative scarring despite administration of mitomycin-C or 5-FU.
In this study, we tried to find statistical correlations of stromal parameters and the clinical data. However, all patients were chronically treated, and in most cases with several antiglaucoma drugs. Based on the limited number of the operated patients in this immunohistochemical study, we did not find correlations between stromal parameters and the clinical data. Furthermore, our study design did not permit the analysis of the influence of a particular active agent or BAK.
Interestingly, it has been observed that timolol and dorzolamide display antioxidative effects in TM tissue (Sacc a et al. 2011) . In more detail, timolol has direct protective effects, whereas dorzolamide exerts antioxidative effects in the presence of intact mitochondria, that is most probably in early phases of glaucoma. All of our glaucoma patients received timolol and about every other were treated with varying periods of dorzolamide. It is possible that these medications exert protective effects in other ocular tissues as well and influence our results. However, no definitive conclusions can be made since all patients were multitreated and sample sizes were small.
Previously we have shown that the presence of various inflammatory cells in the conjunctiva at the time of operation has a significant prognostic effect on the success for DS (Helin et al. 2011) as it has been previously demonstrated also in the case of trabeculectomy (Broadway et al. 1994a, b) . Inflammation has an important role in plaque formation. It mediates initiation, progression and it is related to complications of atherosclerotic lesions (Alexander 1995; Fan & Watanabe 2003) . In the beginning of atherosclerosis formation, monocytes and T lymphocytes adhere to the vascular endothelium. They then migrate into the intima, where macrophages digest lipids forming foam cells. These foam cells further attract CD4+ and CD8+ cells, among others, resulting in chronic inflammation. In our previous study, we have demonstrated that there is chronic inflammation in the conjunctiva of glaucoma patients because of large infiltrates of T lymphocytes, plasma cells and macrophages (Helin et al. 2011). Chronic inflammation was especially related to patients who had failed DS surgery. In our recently published study, we also found increased expressions of certain MMPs and tissue inhibitors of metalloproteinases (TIMPs) in the conjunctival tissue of glaucoma patients (HelinToiviainen et al. 2015) which may be an indicator of altered tissue ECM remodelling in patient samples and it may further have an influence in the normal wound healing process. Thus, it is possible that there is a connection between chronic inflammation, alterations in tissue remodelling (HelinToiviainen et al. 2015; V€ alim€ aki & Uusitalo 2015) expression of extracellular matrix proteins (V€ alim€ aki & Uusitalo 2014) and lipid accumulation resembling a wound healing cascade similar to atherosclerotic plaque formation. These alterations may interfere with the normal wound healing process eventually influencing surgical outcome.
The limitation of this research is that the sample size was small making it more complicated to draw definite and generalized conclusions. Further, the patient selection did not include patients without preoperative treatment, which would have enabled to analyse possible histological alterations related to the disease itself. In addition, including a group of patients treated with timolol and/or dorzolamide would have provided more details of possible antioxidative effects of these drugs to the conjunctiva.
In this research, we have demonstrated increased expression of ox-LDL in glaucoma patients under chronic topical treatment compared with control subjects. In addition, we observed that lipid and calcium aggregates were predominant in those patients whose surgical operation did not succeed. Conjunctival ox-LDL and lipid aggregates might be novel biomarkers of oxidative stress and chronic inflammation in POAG and ExG patients. Furthermore, conjunctival lipid and calcium aggregates may serve as prognostic factors for surgical failure. Our results strengthen the idea that the state of the conjunctiva is of vital importance for the successful glaucoma surgery and that this should be carefully taken into clinical consideration when deciding to proceed to surgery in the treatment of glaucoma.
